Year archive

Appili Therapeutics Inc. — 2022 filings

All 42 regulatory filings released by Appili Therapeutics Inc. (APLI) in 2022, sourced directly from the official regulator.

42 Filings

2022 Period

2022 filings (42)

Filing	Released	Lang
News release - English.pdf Capital/Financing Update	2022-11-14	English
Interim MD&A - English.pdf Interim / Quarterly Report	2022-11-10	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2022-11-10	English
News release - English.pdf Earnings Release	2022-11-10	English
Report of voting results.pdf Declaration of Voting Results & Voting Rights Announcements	2022-09-23	English
News release - English.pdf Declaration of Voting Results & Voting Rights Announcements	2022-09-23	English
Other.pdf Regulatory Filings	2022-08-23	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-08-12	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-08-12	English
Interim MD&A - English.pdf Regulatory Filings	2022-08-12	English
Interim financial statements/report – English.pdf Regulatory Filings	2022-08-12	English
News release - English.pdf Regulatory Filings	2022-08-12	English
News release - English.pdf Investor Presentation	2022-08-02	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2022-07-26	English
Notice of the meeting and record date - French.pdf Declaration of Voting Results & Voting Rights Announcements	2022-07-26	English
Decision Document (Final).pdf Capital/Financing Update	2022-05-18	English
News release - English.pdf Capital/Financing Update	2022-05-18	English
News release - English.pdf Capital/Financing Update	2022-05-17	English
Non-issuer's submission to jurisdiction and appointment of agent.pdf Regulatory Filings	2022-05-16	English
Final short form prospectus – English.pdf Regulatory Filings	2022-05-16	English
Non-issuer's submission to jurisdiction and appointment of agent.pdf Regulatory Filings	2022-05-16	English
Non-issuer's submission to jurisdiction and appointment of agent.pdf Regulatory Filings	2022-05-16	English
Auditors' consent letter.pdf Regulatory Filings	2022-05-16	English
Decision Document (Preliminary).pdf Regulatory Filings	2022-05-05	English
Preliminary short form prospectus – English.pdf Regulatory Filings	2022-05-05	English
Qualification certificate.pdf Regulatory Filings	2022-05-05	English
Preliminary short form prospectus – English.pdf Capital/Financing Update	2022-05-05	English
News release - English.pdf Investor Presentation	2022-04-27	English
News release - English.pdf Regulatory Filings	2022-04-13	English
Report of exempt distribution excluding schedule 1 of Form 5.pdf Regulatory Filings	2022-04-05	English
Material document(s).pdf Regulatory Filings	2022-04-04	English
Material document(s).pdf Regulatory Filings	2022-04-04	English
Material change report - English.pdf Regulatory Filings	2022-04-04	English
News release - English.pdf Capital/Financing Update	2022-03-29	English
News release - English.pdf Capital/Financing Update	2022-02-28	English
52-109F2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2022-02-14	English
52-109F2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2022-02-14	English
Interim MD&A - English.pdf Interim / Quarterly Report	2022-02-14	English
Interim financial statements/report – English.pdf Interim / Quarterly Report	2022-02-14	English
News release - English.pdf Regulatory Filings	2022-02-14	English
News release - English.pdf Interim / Quarterly Report	2022-02-14	English
News release - English.pdf Capital/Financing Update	2022-02-08	English